nodes	percent_of_prediction	percent_of_DWPC	metapath
Irbesartan—CYP2C8—Pyrimethamine—malaria	0.0468	0.0677	CbGbCtD
Irbesartan—CYP2C8—Sulfadiazine—malaria	0.0468	0.0677	CbGbCtD
Irbesartan—CYP3A4—Clindamycin—malaria	0.033	0.0478	CbGbCtD
Irbesartan—CYP2C9—Sulfadiazine—malaria	0.0326	0.0472	CbGbCtD
Irbesartan—CYP2C9—Pyrimethamine—malaria	0.0326	0.0472	CbGbCtD
Irbesartan—PTGS1—Dapsone—malaria	0.0317	0.0458	CbGbCtD
Irbesartan—CYP2D6—Pyrimethamine—malaria	0.0298	0.0432	CbGbCtD
Irbesartan—CYP1A2—Proguanil—malaria	0.029	0.0419	CbGbCtD
Irbesartan—CYP2C9—Artemether—malaria	0.0278	0.0402	CbGbCtD
Irbesartan—CYP2C9—Proguanil—malaria	0.0261	0.0377	CbGbCtD
Irbesartan—CYP2D6—Artemether—malaria	0.0254	0.0367	CbGbCtD
Irbesartan—CYP2C8—Quinine—malaria	0.0241	0.0349	CbGbCtD
Irbesartan—CYP2D6—Proguanil—malaria	0.0239	0.0345	CbGbCtD
Irbesartan—CYP2D6—Quinidine barbiturate—malaria	0.0226	0.0327	CbGbCtD
Irbesartan—CYP2C8—Quinidine—malaria	0.0212	0.0307	CbGbCtD
Irbesartan—CYP1A2—Pentoxifylline—malaria	0.0208	0.0301	CbGbCtD
Irbesartan—CYP3A4—Sulfadiazine—malaria	0.019	0.0275	CbGbCtD
Irbesartan—CYP1A2—Quinine—malaria	0.0187	0.027	CbGbCtD
Irbesartan—CYP2C8—Dapsone—malaria	0.0183	0.0264	CbGbCtD
Irbesartan—CYP2C9—Quinine—malaria	0.0168	0.0243	CbGbCtD
Irbesartan—CYP1A2—Quinidine—malaria	0.0164	0.0237	CbGbCtD
Irbesartan—CYP3A4—Artemether—malaria	0.0161	0.0233	CbGbCtD
Irbesartan—CYP2D6—Quinine—malaria	0.0154	0.0222	CbGbCtD
Irbesartan—CYP3A4—Proguanil—malaria	0.0152	0.0219	CbGbCtD
Irbesartan—CYP2C9—Quinidine—malaria	0.0148	0.0214	CbGbCtD
Irbesartan—CYP3A4—Doxycycline—malaria	0.0144	0.0208	CbGbCtD
Irbesartan—CYP2D6—Quinidine—malaria	0.0135	0.0195	CbGbCtD
Irbesartan—CYP2C9—Dapsone—malaria	0.0127	0.0184	CbGbCtD
Irbesartan—CYP3A4—Quinine—malaria	0.00978	0.0141	CbGbCtD
Irbesartan—CYP3A4—Quinidine—malaria	0.00859	0.0124	CbGbCtD
Irbesartan—CYP3A4—Dapsone—malaria	0.00741	0.0107	CbGbCtD
Irbesartan—JUN—endothelium—malaria	0.00477	0.0751	CbGeAlD
Irbesartan—AGTR1—endothelium—malaria	0.00359	0.0566	CbGeAlD
Irbesartan—AGTR1—blood plasma—malaria	0.00319	0.0502	CbGeAlD
Irbesartan—UGT1A3—digestive system—malaria	0.00288	0.0453	CbGeAlD
Irbesartan—JUN—saliva-secreting gland—malaria	0.00245	0.0387	CbGeAlD
Irbesartan—JUN—hematopoietic system—malaria	0.00234	0.0369	CbGeAlD
Irbesartan—UGT1A3—liver—malaria	0.00214	0.0338	CbGeAlD
Irbesartan—JUN—kidney—malaria	0.00192	0.0302	CbGeAlD
Irbesartan—AGTR1—hematopoietic system—malaria	0.00176	0.0278	CbGeAlD
Irbesartan—CYP2C8—blood plasma—malaria	0.00173	0.0272	CbGeAlD
Irbesartan—JUN—digestive system—malaria	0.00163	0.0257	CbGeAlD
Irbesartan—CYP1A2—blood plasma—malaria	0.00162	0.0255	CbGeAlD
Irbesartan—PTGS1—endothelium—malaria	0.00158	0.0249	CbGeAlD
Irbesartan—JUN—blood—malaria	0.00155	0.0244	CbGeAlD
Irbesartan—CYP2C9—blood plasma—malaria	0.00154	0.0242	CbGeAlD
Irbesartan—JUN—bone marrow—malaria	0.0015	0.0237	CbGeAlD
Irbesartan—AGTR1—kidney—malaria	0.00145	0.0228	CbGeAlD
Irbesartan—PTGS1—blood plasma—malaria	0.0014	0.0221	CbGeAlD
Irbesartan—JUN—liver—malaria	0.00121	0.0191	CbGeAlD
Irbesartan—CYP3A4—blood plasma—malaria	0.00117	0.0185	CbGeAlD
Irbesartan—AGTR1—blood—malaria	0.00117	0.0184	CbGeAlD
Irbesartan—CYP2D6—blood plasma—malaria	0.00115	0.0182	CbGeAlD
Irbesartan—EDNRA—brain—malaria	0.00106	0.0166	CbGeAlD
Irbesartan—JUN—brain—malaria	0.000963	0.0152	CbGeAlD
Irbesartan—CYP2C8—hematopoietic system—malaria	0.000956	0.0151	CbGeAlD
Irbesartan—AGTR1—liver—malaria	0.000914	0.0144	CbGeAlD
Irbesartan—CYP1A2—hematopoietic system—malaria	0.000895	0.0141	CbGeAlD
Irbesartan—CYP2C9—hematopoietic system—malaria	0.000849	0.0134	CbGeAlD
Irbesartan—CYP2C8—kidney—malaria	0.000784	0.0123	CbGeAlD
Irbesartan—PTGS1—hematopoietic system—malaria	0.000775	0.0122	CbGeAlD
Irbesartan—AGTR1—brain—malaria	0.000725	0.0114	CbGeAlD
Irbesartan—CYP3A4—hematopoietic system—malaria	0.000648	0.0102	CbGeAlD
Irbesartan—CYP2D6—hematopoietic system—malaria	0.000637	0.01	CbGeAlD
Irbesartan—PTGS1—kidney—malaria	0.000636	0.01	CbGeAlD
Irbesartan—CYP2C8—blood—malaria	0.000633	0.00998	CbGeAlD
Irbesartan—CYP1A2—digestive system—malaria	0.000622	0.0098	CbGeAlD
Irbesartan—CYP1A2—blood—malaria	0.000593	0.00934	CbGeAlD
Irbesartan—CYP2C9—digestive system—malaria	0.000591	0.0093	CbGeAlD
Irbesartan—CYP2C9—blood—malaria	0.000563	0.00886	CbGeAlD
Irbesartan—PTGS1—digestive system—malaria	0.000539	0.00849	CbGeAlD
Irbesartan—CYP3A4—kidney—malaria	0.000531	0.00836	CbGeAlD
Irbesartan—CYP2D6—kidney—malaria	0.000522	0.00823	CbGeAlD
Irbesartan—PTGS1—blood—malaria	0.000514	0.00809	CbGeAlD
Irbesartan—CYP2C8—liver—malaria	0.000495	0.0078	CbGeAlD
Irbesartan—CYP1A2—liver—malaria	0.000464	0.0073	CbGeAlD
Irbesartan—CYP3A4—digestive system—malaria	0.00045	0.0071	CbGeAlD
Irbesartan—CYP2D6—digestive system—malaria	0.000443	0.00698	CbGeAlD
Irbesartan—CYP2C9—liver—malaria	0.00044	0.00693	CbGeAlD
Irbesartan—CYP3A4—blood—malaria	0.000429	0.00676	CbGeAlD
Irbesartan—CYP2D6—blood—malaria	0.000422	0.00665	CbGeAlD
Irbesartan—CYP2C8—brain—malaria	0.000393	0.00619	CbGeAlD
Irbesartan—CYP3A4—liver—malaria	0.000336	0.00529	CbGeAlD
Irbesartan—CYP2D6—liver—malaria	0.00033	0.0052	CbGeAlD
Irbesartan—PTGS1—brain—malaria	0.000319	0.00502	CbGeAlD
Irbesartan—Musculoskeletal discomfort—Sulfadiazine—malaria	0.0003	0.00161	CcSEcCtD
Irbesartan—Urethral disorder—Quinidine barbiturate—malaria	0.000299	0.00161	CcSEcCtD
Irbesartan—Flatulence—Clindamycin—malaria	0.000296	0.00159	CcSEcCtD
Irbesartan—Malnutrition—Quinidine—malaria	0.000294	0.00159	CcSEcCtD
Irbesartan—Erythema—Quinidine—malaria	0.000294	0.00159	CcSEcCtD
Irbesartan—Erythema—Quinine—malaria	0.000294	0.00159	CcSEcCtD
Irbesartan—Malnutrition—Quinine—malaria	0.000294	0.00159	CcSEcCtD
Irbesartan—Nausea—Proguanil—malaria	0.000294	0.00158	CcSEcCtD
Irbesartan—Visual impairment—Quinidine barbiturate—malaria	0.000294	0.00158	CcSEcCtD
Irbesartan—Dysgeusia—Clindamycin—malaria	0.000294	0.00158	CcSEcCtD
Irbesartan—Vision blurred—Dapsone—malaria	0.000292	0.00157	CcSEcCtD
Irbesartan—Muscle spasms—Clindamycin—malaria	0.000288	0.00155	CcSEcCtD
Irbesartan—Decreased appetite—Sulfadiazine—malaria	0.000286	0.00154	CcSEcCtD
Irbesartan—Tinnitus—Quinidine barbiturate—malaria	0.000285	0.00153	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Sulfadiazine—malaria	0.000284	0.00153	CcSEcCtD
Irbesartan—Flushing—Quinidine barbiturate—malaria	0.000283	0.00153	CcSEcCtD
Irbesartan—Cardiac disorder—Quinidine barbiturate—malaria	0.000283	0.00153	CcSEcCtD
Irbesartan—Flushing—Pentoxifylline—malaria	0.000283	0.00152	CcSEcCtD
Irbesartan—Vertigo—Dapsone—malaria	0.000279	0.0015	CcSEcCtD
Irbesartan—Vision blurred—Quinidine—malaria	0.000277	0.00149	CcSEcCtD
Irbesartan—Vision blurred—Quinine—malaria	0.000277	0.00149	CcSEcCtD
Irbesartan—Anaemia—Clindamycin—malaria	0.000277	0.00149	CcSEcCtD
Irbesartan—Tremor—Quinidine—malaria	0.000276	0.00149	CcSEcCtD
Irbesartan—Tremor—Quinine—malaria	0.000276	0.00149	CcSEcCtD
Irbesartan—Immune system disorder—Quinidine barbiturate—malaria	0.000276	0.00148	CcSEcCtD
Irbesartan—Immune system disorder—Pentoxifylline—malaria	0.000275	0.00148	CcSEcCtD
Irbesartan—Mediastinal disorder—Quinidine barbiturate—malaria	0.000275	0.00148	CcSEcCtD
Irbesartan—Chills—Quinidine barbiturate—malaria	0.000274	0.00147	CcSEcCtD
Irbesartan—Arrhythmia—Pentoxifylline—malaria	0.000272	0.00147	CcSEcCtD
Irbesartan—Cough—Dapsone—malaria	0.000271	0.00146	CcSEcCtD
Irbesartan—Agitation—Quinidine—malaria	0.000271	0.00146	CcSEcCtD
Irbesartan—Agitation—Quinine—malaria	0.000271	0.00146	CcSEcCtD
Irbesartan—Vertigo—Clindamycin—malaria	0.00027	0.00145	CcSEcCtD
Irbesartan—Angioedema—Quinidine—malaria	0.000269	0.00145	CcSEcCtD
Irbesartan—Angioedema—Quinine—malaria	0.000269	0.00145	CcSEcCtD
Irbesartan—Gastrointestinal pain—Sulfadiazine—malaria	0.000269	0.00145	CcSEcCtD
Irbesartan—Leukopenia—Clindamycin—malaria	0.000269	0.00145	CcSEcCtD
Irbesartan—Erythema—Quinidine barbiturate—malaria	0.000266	0.00143	CcSEcCtD
Irbesartan—Malnutrition—Quinidine barbiturate—malaria	0.000266	0.00143	CcSEcCtD
Irbesartan—Erythema—Pentoxifylline—malaria	0.000265	0.00143	CcSEcCtD
Irbesartan—Vertigo—Quinidine—malaria	0.000264	0.00142	CcSEcCtD
Irbesartan—Vertigo—Quinine—malaria	0.000264	0.00142	CcSEcCtD
Irbesartan—Syncope—Quinidine—malaria	0.000264	0.00142	CcSEcCtD
Irbesartan—Syncope—Quinine—malaria	0.000264	0.00142	CcSEcCtD
Irbesartan—Leukopenia—Quinine—malaria	0.000263	0.00142	CcSEcCtD
Irbesartan—Leukopenia—Quinidine—malaria	0.000263	0.00142	CcSEcCtD
Irbesartan—CYP2D6—brain—malaria	0.000262	0.00413	CbGeAlD
Irbesartan—Flatulence—Pentoxifylline—malaria	0.000261	0.00141	CcSEcCtD
Irbesartan—Urticaria—Sulfadiazine—malaria	0.000261	0.00141	CcSEcCtD
Irbesartan—Tension—Quinidine barbiturate—malaria	0.000261	0.0014	CcSEcCtD
Irbesartan—Tension—Pentoxifylline—malaria	0.00026	0.0014	CcSEcCtD
Irbesartan—Abdominal pain—Sulfadiazine—malaria	0.00026	0.0014	CcSEcCtD
Irbesartan—Body temperature increased—Sulfadiazine—malaria	0.00026	0.0014	CcSEcCtD
Irbesartan—Dysgeusia—Pentoxifylline—malaria	0.00026	0.0014	CcSEcCtD
Irbesartan—Hypertension—Clindamycin—malaria	0.000259	0.0014	CcSEcCtD
Irbesartan—Loss of consciousness—Quinine—malaria	0.000259	0.00139	CcSEcCtD
Irbesartan—Loss of consciousness—Quinidine—malaria	0.000259	0.00139	CcSEcCtD
Irbesartan—Nervousness—Quinidine barbiturate—malaria	0.000258	0.00139	CcSEcCtD
Irbesartan—Nervousness—Pentoxifylline—malaria	0.000258	0.00139	CcSEcCtD
Irbesartan—Muscle spasms—Pentoxifylline—malaria	0.000255	0.00137	CcSEcCtD
Irbesartan—Discomfort—Clindamycin—malaria	0.000252	0.00136	CcSEcCtD
Irbesartan—Myalgia—Quinine—malaria	0.000251	0.00135	CcSEcCtD
Irbesartan—Chest pain—Quinine—malaria	0.000251	0.00135	CcSEcCtD
Irbesartan—Chest pain—Quinidine—malaria	0.000251	0.00135	CcSEcCtD
Irbesartan—Myalgia—Quinidine—malaria	0.000251	0.00135	CcSEcCtD
Irbesartan—Vision blurred—Quinidine barbiturate—malaria	0.00025	0.00135	CcSEcCtD
Irbesartan—Vision blurred—Pentoxifylline—malaria	0.00025	0.00135	CcSEcCtD
Irbesartan—Tremor—Quinidine barbiturate—malaria	0.000249	0.00134	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000249	0.00134	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000249	0.00134	CcSEcCtD
Irbesartan—Tremor—Pentoxifylline—malaria	0.000248	0.00134	CcSEcCtD
Irbesartan—Tachycardia—Dapsone—malaria	0.000247	0.00133	CcSEcCtD
Irbesartan—Ill-defined disorder—Pentoxifylline—malaria	0.000246	0.00133	CcSEcCtD
Irbesartan—Anaemia—Pentoxifylline—malaria	0.000245	0.00132	CcSEcCtD
Irbesartan—Anaphylactic shock—Clindamycin—malaria	0.000245	0.00132	CcSEcCtD
Irbesartan—Agitation—Quinidine barbiturate—malaria	0.000244	0.00131	CcSEcCtD
Irbesartan—Agitation—Pentoxifylline—malaria	0.000244	0.00131	CcSEcCtD
Irbesartan—Angioedema—Quinidine barbiturate—malaria	0.000243	0.00131	CcSEcCtD
Irbesartan—Angioedema—Pentoxifylline—malaria	0.000242	0.0013	CcSEcCtD
Irbesartan—Hypersensitivity—Sulfadiazine—malaria	0.000242	0.0013	CcSEcCtD
Irbesartan—Oedema—Quinidine—malaria	0.00024	0.00129	CcSEcCtD
Irbesartan—Oedema—Quinine—malaria	0.00024	0.00129	CcSEcCtD
Irbesartan—Thrombocytopenia—Clindamycin—malaria	0.00024	0.00129	CcSEcCtD
Irbesartan—Malaise—Pentoxifylline—malaria	0.000239	0.00129	CcSEcCtD
Irbesartan—Vertigo—Quinidine barbiturate—malaria	0.000239	0.00129	CcSEcCtD
Irbesartan—Syncope—Quinidine barbiturate—malaria	0.000238	0.00128	CcSEcCtD
Irbesartan—Leukopenia—Quinidine barbiturate—malaria	0.000238	0.00128	CcSEcCtD
Irbesartan—Leukopenia—Pentoxifylline—malaria	0.000237	0.00128	CcSEcCtD
Irbesartan—Shock—Quinidine—malaria	0.000236	0.00127	CcSEcCtD
Irbesartan—Shock—Quinine—malaria	0.000236	0.00127	CcSEcCtD
Irbesartan—Nervous system disorder—Quinidine—malaria	0.000236	0.00127	CcSEcCtD
Irbesartan—Nervous system disorder—Quinine—malaria	0.000236	0.00127	CcSEcCtD
Irbesartan—Thrombocytopenia—Quinidine—malaria	0.000235	0.00127	CcSEcCtD
Irbesartan—Thrombocytopenia—Quinine—malaria	0.000235	0.00127	CcSEcCtD
Irbesartan—Tachycardia—Quinidine—malaria	0.000234	0.00126	CcSEcCtD
Irbesartan—Tachycardia—Quinine—malaria	0.000234	0.00126	CcSEcCtD
Irbesartan—Loss of consciousness—Quinidine barbiturate—malaria	0.000233	0.00126	CcSEcCtD
Irbesartan—Skin disorder—Quinidine—malaria	0.000233	0.00126	CcSEcCtD
Irbesartan—Skin disorder—Quinine—malaria	0.000233	0.00126	CcSEcCtD
Irbesartan—Pruritus—Sulfadiazine—malaria	0.000233	0.00125	CcSEcCtD
Irbesartan—Hyperhidrosis—Quinine—malaria	0.000232	0.00125	CcSEcCtD
Irbesartan—Hyperhidrosis—Quinidine—malaria	0.000232	0.00125	CcSEcCtD
Irbesartan—Anorexia—Quinine—malaria	0.000229	0.00123	CcSEcCtD
Irbesartan—Anorexia—Quinidine—malaria	0.000229	0.00123	CcSEcCtD
Irbesartan—Hypertension—Pentoxifylline—malaria	0.000229	0.00123	CcSEcCtD
Irbesartan—Hypotension—Clindamycin—malaria	0.000229	0.00123	CcSEcCtD
Irbesartan—Myalgia—Quinidine barbiturate—malaria	0.000226	0.00122	CcSEcCtD
Irbesartan—Chest pain—Quinidine barbiturate—malaria	0.000226	0.00122	CcSEcCtD
Irbesartan—Arthralgia—Quinidine barbiturate—malaria	0.000226	0.00122	CcSEcCtD
Irbesartan—Chest pain—Pentoxifylline—malaria	0.000226	0.00122	CcSEcCtD
Irbesartan—Myalgia—Pentoxifylline—malaria	0.000226	0.00122	CcSEcCtD
Irbesartan—Anxiety—Quinidine barbiturate—malaria	0.000225	0.00121	CcSEcCtD
Irbesartan—Diarrhoea—Sulfadiazine—malaria	0.000225	0.00121	CcSEcCtD
Irbesartan—Anxiety—Pentoxifylline—malaria	0.000225	0.00121	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000225	0.00121	CcSEcCtD
Irbesartan—Hypotension—Quinine—malaria	0.000224	0.00121	CcSEcCtD
Irbesartan—Hypotension—Quinidine—malaria	0.000224	0.00121	CcSEcCtD
Irbesartan—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000224	0.00121	CcSEcCtD
Irbesartan—Discomfort—Pentoxifylline—malaria	0.000223	0.0012	CcSEcCtD
Irbesartan—Dry mouth—Pentoxifylline—malaria	0.000221	0.00119	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Quinidine—malaria	0.000219	0.00118	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Quinine—malaria	0.000219	0.00118	CcSEcCtD
Irbesartan—Dyspnoea—Clindamycin—malaria	0.000218	0.00118	CcSEcCtD
Irbesartan—Oedema—Quinidine barbiturate—malaria	0.000217	0.00117	CcSEcCtD
Irbesartan—Anaphylactic shock—Pentoxifylline—malaria	0.000216	0.00117	CcSEcCtD
Irbesartan—Oedema—Pentoxifylline—malaria	0.000216	0.00117	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000216	0.00363	CbGpPWpGaD
Irbesartan—Dyspepsia—Clindamycin—malaria	0.000216	0.00116	CcSEcCtD
Irbesartan—Infection—Pentoxifylline—malaria	0.000215	0.00116	CcSEcCtD
Irbesartan—Dyspnoea—Quinidine—malaria	0.000214	0.00115	CcSEcCtD
Irbesartan—Dyspnoea—Quinine—malaria	0.000214	0.00115	CcSEcCtD
Irbesartan—Shock—Quinidine barbiturate—malaria	0.000213	0.00115	CcSEcCtD
Irbesartan—Shock—Pentoxifylline—malaria	0.000213	0.00115	CcSEcCtD
Irbesartan—Nervous system disorder—Quinidine barbiturate—malaria	0.000213	0.00115	CcSEcCtD
Irbesartan—Thrombocytopenia—Quinidine barbiturate—malaria	0.000212	0.00114	CcSEcCtD
Irbesartan—Thrombocytopenia—Pentoxifylline—malaria	0.000212	0.00114	CcSEcCtD
Irbesartan—Tachycardia—Quinidine barbiturate—malaria	0.000212	0.00114	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Clindamycin—malaria	0.000211	0.00114	CcSEcCtD
Irbesartan—Tachycardia—Pentoxifylline—malaria	0.000211	0.00114	CcSEcCtD
Irbesartan—Fatigue—Clindamycin—malaria	0.000211	0.00114	CcSEcCtD
Irbesartan—Skin disorder—Quinidine barbiturate—malaria	0.000211	0.00113	CcSEcCtD
Irbesartan—Skin disorder—Pentoxifylline—malaria	0.00021	0.00113	CcSEcCtD
Irbesartan—Hyperhidrosis—Quinidine barbiturate—malaria	0.00021	0.00113	CcSEcCtD
Irbesartan—Pain—Clindamycin—malaria	0.000209	0.00113	CcSEcCtD
Irbesartan—Constipation—Clindamycin—malaria	0.000209	0.00113	CcSEcCtD
Irbesartan—Hyperhidrosis—Pentoxifylline—malaria	0.000209	0.00113	CcSEcCtD
Irbesartan—Vomiting—Sulfadiazine—malaria	0.000209	0.00113	CcSEcCtD
Irbesartan—Decreased appetite—Quinidine—malaria	0.000209	0.00112	CcSEcCtD
Irbesartan—Decreased appetite—Quinine—malaria	0.000209	0.00112	CcSEcCtD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—malaria	0.000208	0.00349	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Quinidine—malaria	0.000207	0.00112	CcSEcCtD
Irbesartan—Gastrointestinal disorder—Quinine—malaria	0.000207	0.00112	CcSEcCtD
Irbesartan—Rash—Sulfadiazine—malaria	0.000207	0.00112	CcSEcCtD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—ICAM1—malaria	0.000207	0.00348	CbGpPWpGaD
Irbesartan—Dermatitis—Sulfadiazine—malaria	0.000207	0.00112	CcSEcCtD
Irbesartan—Gastrointestinal pain—Dapsone—malaria	0.000207	0.00111	CcSEcCtD
Irbesartan—Anorexia—Quinidine barbiturate—malaria	0.000207	0.00111	CcSEcCtD
Irbesartan—Anorexia—Pentoxifylline—malaria	0.000206	0.00111	CcSEcCtD
Irbesartan—Headache—Sulfadiazine—malaria	0.000206	0.00111	CcSEcCtD
Irbesartan—JUN—ATF-2 transcription factor network—IFNG—malaria	0.000205	0.00344	CbGpPWpGaD
Irbesartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—malaria	0.000203	0.00341	CbGpPWpGaD
Irbesartan—Hypotension—Quinidine barbiturate—malaria	0.000203	0.00109	CcSEcCtD
Irbesartan—CYP1A2—Arachidonic acid metabolism—HPGDS—malaria	0.000202	0.00339	CbGpPWpGaD
Irbesartan—Hypotension—Pentoxifylline—malaria	0.000202	0.00109	CcSEcCtD
Irbesartan—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000201	0.00337	CbGpPWpGaD
Irbesartan—Gastrointestinal pain—Clindamycin—malaria	0.0002	0.00108	CcSEcCtD
Irbesartan—Body temperature increased—Dapsone—malaria	0.0002	0.00108	CcSEcCtD
Irbesartan—Abdominal pain—Dapsone—malaria	0.0002	0.00108	CcSEcCtD
Irbesartan—Feeling abnormal—Quinidine—malaria	0.000198	0.00107	CcSEcCtD
Irbesartan—Feeling abnormal—Quinine—malaria	0.000198	0.00107	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000198	0.00106	CcSEcCtD
Irbesartan—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000197	0.00106	CcSEcCtD
Irbesartan—Gastrointestinal pain—Quinine—malaria	0.000196	0.00106	CcSEcCtD
Irbesartan—Gastrointestinal pain—Quinidine—malaria	0.000196	0.00106	CcSEcCtD
Irbesartan—JUN—IL2-mediated signaling events—IL2—malaria	0.000196	0.00328	CbGpPWpGaD
Irbesartan—Nausea—Sulfadiazine—malaria	0.000195	0.00105	CcSEcCtD
Irbesartan—Urticaria—Clindamycin—malaria	0.000195	0.00105	CcSEcCtD
Irbesartan—AGTR1—Allograft Rejection—IL1B—malaria	0.000194	0.00326	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—TLR4—malaria	0.000194	0.00325	CbGpPWpGaD
Irbesartan—JUN—IL-1 signaling pathway—IL1B—malaria	0.000194	0.00325	CbGpPWpGaD
Irbesartan—Body temperature increased—Clindamycin—malaria	0.000194	0.00104	CcSEcCtD
Irbesartan—Abdominal pain—Clindamycin—malaria	0.000194	0.00104	CcSEcCtD
Irbesartan—JUN—Activated TLR4 signalling—CD36—malaria	0.000194	0.00325	CbGpPWpGaD
Irbesartan—Dyspnoea—Quinidine barbiturate—malaria	0.000193	0.00104	CcSEcCtD
Irbesartan—AGTR1—Allograft Rejection—IL2—malaria	0.000193	0.00324	CbGpPWpGaD
Irbesartan—Dyspnoea—Pentoxifylline—malaria	0.000193	0.00104	CcSEcCtD
Irbesartan—Somnolence—Quinidine barbiturate—malaria	0.000193	0.00104	CcSEcCtD
Irbesartan—Somnolence—Pentoxifylline—malaria	0.000192	0.00104	CcSEcCtD
Irbesartan—Urticaria—Quinine—malaria	0.000191	0.00103	CcSEcCtD
Irbesartan—Urticaria—Quinidine—malaria	0.000191	0.00103	CcSEcCtD
Irbesartan—Dyspepsia—Pentoxifylline—malaria	0.000191	0.00103	CcSEcCtD
Irbesartan—Abdominal pain—Quinidine—malaria	0.00019	0.00102	CcSEcCtD
Irbesartan—Body temperature increased—Quinine—malaria	0.00019	0.00102	CcSEcCtD
Irbesartan—Body temperature increased—Quinidine—malaria	0.00019	0.00102	CcSEcCtD
Irbesartan—Abdominal pain—Quinine—malaria	0.00019	0.00102	CcSEcCtD
Irbesartan—Decreased appetite—Quinidine barbiturate—malaria	0.000188	0.00102	CcSEcCtD
Irbesartan—Decreased appetite—Pentoxifylline—malaria	0.000188	0.00101	CcSEcCtD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—IFNG—malaria	0.000188	0.00315	CbGpPWpGaD
Irbesartan—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000187	0.00101	CcSEcCtD
Irbesartan—JUN—MyD88-independent cascade—TLR4—malaria	0.000186	0.00312	CbGpPWpGaD
Irbesartan—Pain—Quinidine barbiturate—malaria	0.000185	0.000999	CcSEcCtD
Irbesartan—Constipation—Quinidine barbiturate—malaria	0.000185	0.000999	CcSEcCtD
Irbesartan—PTGS1—Overview of nanoparticle effects—IL6—malaria	0.000185	0.00311	CbGpPWpGaD
Irbesartan—Constipation—Pentoxifylline—malaria	0.000185	0.000997	CcSEcCtD
Irbesartan—JUN—Regulation of Telomerase—IFNG—malaria	0.000183	0.00307	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000183	0.00307	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—CD36—malaria	0.000182	0.00305	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TLR4—malaria	0.000182	0.00305	CbGpPWpGaD
Irbesartan—Hypersensitivity—Clindamycin—malaria	0.00018	0.000972	CcSEcCtD
Irbesartan—JUN—AP-1 transcription factor network—IFNG—malaria	0.000179	0.003	CbGpPWpGaD
Irbesartan—Feeling abnormal—Quinidine barbiturate—malaria	0.000179	0.000962	CcSEcCtD
Irbesartan—Feeling abnormal—Pentoxifylline—malaria	0.000178	0.00096	CcSEcCtD
Irbesartan—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000177	0.000955	CcSEcCtD
Irbesartan—Hypersensitivity—Quinidine—malaria	0.000177	0.000953	CcSEcCtD
Irbesartan—Hypersensitivity—Quinine—malaria	0.000177	0.000953	CcSEcCtD
Irbesartan—Gastrointestinal pain—Pentoxifylline—malaria	0.000177	0.000953	CcSEcCtD
Irbesartan—Asthenia—Clindamycin—malaria	0.000176	0.000946	CcSEcCtD
Irbesartan—JUN—FAS pathway and Stress induction of HSP regulation—TNF—malaria	0.000174	0.00293	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—TNF—malaria	0.000174	0.00293	CbGpPWpGaD
Irbesartan—Pruritus—Clindamycin—malaria	0.000173	0.000933	CcSEcCtD
Irbesartan—Asthenia—Quinidine—malaria	0.000172	0.000928	CcSEcCtD
Irbesartan—Asthenia—Quinine—malaria	0.000172	0.000928	CcSEcCtD
Irbesartan—Urticaria—Quinidine barbiturate—malaria	0.000172	0.000928	CcSEcCtD
Irbesartan—Urticaria—Pentoxifylline—malaria	0.000172	0.000926	CcSEcCtD
Irbesartan—Body temperature increased—Quinidine barbiturate—malaria	0.000171	0.000923	CcSEcCtD
Irbesartan—Abdominal pain—Quinidine barbiturate—malaria	0.000171	0.000923	CcSEcCtD
Irbesartan—Abdominal pain—Pentoxifylline—malaria	0.000171	0.000921	CcSEcCtD
Irbesartan—Body temperature increased—Pentoxifylline—malaria	0.000171	0.000921	CcSEcCtD
Irbesartan—Pruritus—Quinidine—malaria	0.00017	0.000915	CcSEcCtD
Irbesartan—Pruritus—Quinine—malaria	0.00017	0.000915	CcSEcCtD
Irbesartan—PTGS1—Biological oxidations—HPGDS—malaria	0.000168	0.00281	CbGpPWpGaD
Irbesartan—Diarrhoea—Clindamycin—malaria	0.000168	0.000902	CcSEcCtD
Irbesartan—JUN—Activated TLR4 signalling—TLR4—malaria	0.000167	0.00281	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—IL2—malaria	0.000167	0.0028	CbGpPWpGaD
Irbesartan—Diarrhoea—Quinidine—malaria	0.000164	0.000885	CcSEcCtD
Irbesartan—Diarrhoea—Quinine—malaria	0.000164	0.000885	CcSEcCtD
Irbesartan—JUN—Regulation of Telomerase—IL2—malaria	0.000163	0.00273	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—CD36—malaria	0.000162	0.00272	CbGpPWpGaD
Irbesartan—JUN—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000162	0.00272	CbGpPWpGaD
Irbesartan—Dizziness—Clindamycin—malaria	0.000162	0.000872	CcSEcCtD
Irbesartan—Vomiting—Dapsone—malaria	0.000161	0.000867	CcSEcCtD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL10—malaria	0.00016	0.00269	CbGpPWpGaD
Irbesartan—Hypersensitivity—Quinidine barbiturate—malaria	0.00016	0.00086	CcSEcCtD
Irbesartan—Hypersensitivity—Pentoxifylline—malaria	0.000159	0.000859	CcSEcCtD
Irbesartan—JUN—AP-1 transcription factor network—IL2—malaria	0.000159	0.00267	CbGpPWpGaD
Irbesartan—Dizziness—Quinine—malaria	0.000159	0.000856	CcSEcCtD
Irbesartan—Dizziness—Quinidine—malaria	0.000159	0.000856	CcSEcCtD
Irbesartan—Headache—Dapsone—malaria	0.000159	0.000854	CcSEcCtD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IFNG—malaria	0.000158	0.00265	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—TLR4—malaria	0.000157	0.00264	CbGpPWpGaD
Irbesartan—JUN—Direct p53 effectors—FAS—malaria	0.000157	0.00263	CbGpPWpGaD
Irbesartan—JUN—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—malaria	0.000156	0.00261	CbGpPWpGaD
Irbesartan—Vomiting—Clindamycin—malaria	0.000156	0.000839	CcSEcCtD
Irbesartan—Asthenia—Quinidine barbiturate—malaria	0.000156	0.000838	CcSEcCtD
Irbesartan—Asthenia—Pentoxifylline—malaria	0.000155	0.000836	CcSEcCtD
Irbesartan—Rash—Clindamycin—malaria	0.000154	0.000832	CcSEcCtD
Irbesartan—Dermatitis—Clindamycin—malaria	0.000154	0.000831	CcSEcCtD
Irbesartan—EDNRA—Signaling by GPCR—ACKR1—malaria	0.000154	0.00258	CbGpPWpGaD
Irbesartan—Headache—Clindamycin—malaria	0.000153	0.000826	CcSEcCtD
Irbesartan—Pruritus—Quinidine barbiturate—malaria	0.000153	0.000826	CcSEcCtD
Irbesartan—Pruritus—Pentoxifylline—malaria	0.000153	0.000825	CcSEcCtD
Irbesartan—Vomiting—Quinidine—malaria	0.000153	0.000823	CcSEcCtD
Irbesartan—Vomiting—Quinine—malaria	0.000153	0.000823	CcSEcCtD
Irbesartan—JUN—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—malaria	0.000152	0.00254	CbGpPWpGaD
Irbesartan—Rash—Quinine—malaria	0.000151	0.000816	CcSEcCtD
Irbesartan—Rash—Quinidine—malaria	0.000151	0.000816	CcSEcCtD
Irbesartan—Dermatitis—Quinidine—malaria	0.000151	0.000815	CcSEcCtD
Irbesartan—Dermatitis—Quinine—malaria	0.000151	0.000815	CcSEcCtD
Irbesartan—Headache—Quinidine—malaria	0.000151	0.000811	CcSEcCtD
Irbesartan—Headache—Quinine—malaria	0.000151	0.000811	CcSEcCtD
Irbesartan—Nausea—Dapsone—malaria	0.00015	0.00081	CcSEcCtD
Irbesartan—PTGS1—Selenium Micronutrient Network—CRP—malaria	0.000149	0.0025	CbGpPWpGaD
Irbesartan—Diarrhoea—Quinidine barbiturate—malaria	0.000148	0.000799	CcSEcCtD
Irbesartan—Diarrhoea—Pentoxifylline—malaria	0.000148	0.000797	CcSEcCtD
Irbesartan—Nausea—Clindamycin—malaria	0.000145	0.000783	CcSEcCtD
Irbesartan—JUN—Innate Immune System—TIRAP—malaria	0.000144	0.00242	CbGpPWpGaD
Irbesartan—Dizziness—Quinidine barbiturate—malaria	0.000143	0.000772	CcSEcCtD
Irbesartan—Dizziness—Pentoxifylline—malaria	0.000143	0.000771	CcSEcCtD
Irbesartan—Nausea—Quinidine—malaria	0.000143	0.000769	CcSEcCtD
Irbesartan—Nausea—Quinine—malaria	0.000143	0.000769	CcSEcCtD
Irbesartan—JUN—TGF-beta Receptor Signaling—TNF—malaria	0.000143	0.00239	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TLR4—malaria	0.000142	0.00238	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—CD4—malaria	0.000141	0.00237	CbGpPWpGaD
Irbesartan—AGTR1—Allograft Rejection—TNF—malaria	0.000141	0.00236	CbGpPWpGaD
Irbesartan—JUN—TWEAK Signaling Pathway—IL6—malaria	0.000141	0.00236	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL2—malaria	0.00014	0.00235	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—TLR4—malaria	0.00014	0.00235	CbGpPWpGaD
Irbesartan—JUN—FCERI mediated MAPK activation—IL6—malaria	0.000138	0.00232	CbGpPWpGaD
Irbesartan—Vomiting—Quinidine barbiturate—malaria	0.000138	0.000742	CcSEcCtD
Irbesartan—Vomiting—Pentoxifylline—malaria	0.000138	0.000741	CcSEcCtD
Irbesartan—PTGS1—Selenium Micronutrient Network—ICAM1—malaria	0.000137	0.00229	CbGpPWpGaD
Irbesartan—Rash—Quinidine barbiturate—malaria	0.000137	0.000736	CcSEcCtD
Irbesartan—Dermatitis—Quinidine barbiturate—malaria	0.000137	0.000736	CcSEcCtD
Irbesartan—Rash—Pentoxifylline—malaria	0.000136	0.000735	CcSEcCtD
Irbesartan—Dermatitis—Pentoxifylline—malaria	0.000136	0.000734	CcSEcCtD
Irbesartan—Headache—Quinidine barbiturate—malaria	0.000136	0.000731	CcSEcCtD
Irbesartan—Headache—Pentoxifylline—malaria	0.000136	0.00073	CcSEcCtD
Irbesartan—JUN—MAPK Signaling Pathway—FAS—malaria	0.000135	0.00227	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CR1—malaria	0.000134	0.00225	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL1B—malaria	0.000131	0.00219	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IFNG—malaria	0.000129	0.00217	CbGpPWpGaD
Irbesartan—Nausea—Quinidine barbiturate—malaria	0.000129	0.000694	CcSEcCtD
Irbesartan—CYP1A2—Phase II conjugation—HPGDS—malaria	0.000129	0.00216	CbGpPWpGaD
Irbesartan—JUN—IL6-mediated signaling events—IL6—malaria	0.000129	0.00216	CbGpPWpGaD
Irbesartan—Nausea—Pentoxifylline—malaria	0.000129	0.000692	CcSEcCtD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—CD36—malaria	0.000125	0.00209	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000122	0.00205	CbGpPWpGaD
Irbesartan—JUN—Downstream signaling in naïve CD8+ T cells—TNF—malaria	0.000121	0.00204	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—ACKR1—malaria	0.000121	0.00202	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL1B—malaria	0.000118	0.00198	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000117	0.00197	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—FAS—malaria	0.000117	0.00197	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—DHODH—malaria	0.000116	0.00195	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL1B—malaria	0.000115	0.00194	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR9—malaria	0.000114	0.00191	CbGpPWpGaD
Irbesartan—JUN—MAP kinase activation in TLR cascade—IL6—malaria	0.000112	0.00188	CbGpPWpGaD
Irbesartan—JUN—Focal Adhesion—KDR—malaria	0.00011	0.00185	CbGpPWpGaD
Irbesartan—CYP2C8—Biological oxidations—HPGDS—malaria	0.000108	0.00182	CbGpPWpGaD
Irbesartan—JUN—ATF-2 transcription factor network—IL6—malaria	0.000107	0.0018	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IFNG—malaria	0.000104	0.00175	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—NOS2—malaria	0.0001	0.00168	CbGpPWpGaD
Irbesartan—JUN—Apoptosis—TNF—malaria	0.0001	0.00168	CbGpPWpGaD
Irbesartan—JUN—Immune System—CISH—malaria	9.98e-05	0.00167	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SLC4A1—malaria	9.88e-05	0.00166	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCGR2B—malaria	9.43e-05	0.00158	CbGpPWpGaD
Irbesartan—JUN—AP-1 transcription factor network—IL6—malaria	9.35e-05	0.00157	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—TNF—malaria	9.31e-05	0.00156	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—DECR1—malaria	9.29e-05	0.00156	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL1B—malaria	9.28e-05	0.00156	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL1B—malaria	9.22e-05	0.00155	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—FCGR2A—malaria	9.12e-05	0.00153	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—ACKR1—malaria	9.09e-05	0.00152	CbGpPWpGaD
Irbesartan—CYP2D6—Biological oxidations—HPGDS—malaria	8.89e-05	0.00149	CbGpPWpGaD
Irbesartan—JUN—TRAF6 Mediated Induction of proinflammatory cytokines—IL6—malaria	8.85e-05	0.00148	CbGpPWpGaD
Irbesartan—CYP2C9—Biological oxidations—HPGDS—malaria	8.81e-05	0.00148	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—TNF—malaria	8.57e-05	0.00144	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL1B—malaria	8.45e-05	0.00142	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL1B—malaria	8.41e-05	0.00141	CbGpPWpGaD
Irbesartan—JUN—Immune System—TIRAP—malaria	8.4e-05	0.00141	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—HBB—malaria	8.4e-05	0.00141	CbGpPWpGaD
Irbesartan—JUN—Glucocorticoid receptor regulatory network—IL6—malaria	8.24e-05	0.00138	CbGpPWpGaD
Irbesartan—JUN—MyD88 cascade initiated on plasma membrane—IL6—malaria	8.01e-05	0.00134	CbGpPWpGaD
Irbesartan—JUN—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—malaria	7.93e-05	0.00133	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—IL1B—malaria	7.93e-05	0.00133	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	7.86e-05	0.00132	CbGpPWpGaD
Irbesartan—JUN—Immune System—CR1—malaria	7.81e-05	0.00131	CbGpPWpGaD
Irbesartan—JUN—MyD88 dependent cascade initiated on endosome—IL6—malaria	7.79e-05	0.00131	CbGpPWpGaD
Irbesartan—JUN—TCR Signaling Pathway—IL6—malaria	7.65e-05	0.00128	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—DECR1—malaria	7.59e-05	0.00127	CbGpPWpGaD
Irbesartan—CYP1A2—Biological oxidations—HPGDS—malaria	7.53e-05	0.00126	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 9 (TLR9) Cascade—IL6—malaria	7.51e-05	0.00126	CbGpPWpGaD
Irbesartan—JUN—TNF alpha Signaling Pathway—IL6—malaria	7.51e-05	0.00126	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—PKLR—malaria	7.49e-05	0.00126	CbGpPWpGaD
Irbesartan—JUN—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	7.39e-05	0.00124	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—TLR9—malaria	7.32e-05	0.00123	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—ACKR1—malaria	7.13e-05	0.0012	CbGpPWpGaD
Irbesartan—JUN—MyD88-independent cascade—IL6—malaria	7.09e-05	0.00119	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	7.01e-05	0.00118	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	6.98e-05	0.00117	CbGpPWpGaD
Irbesartan—JUN—Toll-like Receptor Signaling Pathway—IL6—malaria	6.92e-05	0.00116	CbGpPWpGaD
Irbesartan—JUN—Senescence and Autophagy in Cancer—IL6—malaria	6.76e-05	0.00113	CbGpPWpGaD
Irbesartan—JUN—Senescence-Associated Secretory Phenotype (SASP)—IL6—malaria	6.76e-05	0.00113	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—TNF—malaria	6.74e-05	0.00113	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—TNF—malaria	6.69e-05	0.00112	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—G6PD—malaria	6.67e-05	0.00112	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR9—malaria	6.64e-05	0.00111	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DHODH—malaria	6.54e-05	0.0011	CbGpPWpGaD
Irbesartan—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	6.5e-05	0.00109	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—malaria	6.44e-05	0.00108	CbGpPWpGaD
Irbesartan—JUN—Activated TLR4 signalling—IL6—malaria	6.37e-05	0.00107	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—DECR1—malaria	6.17e-05	0.00104	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—TNF—malaria	6.1e-05	0.00102	CbGpPWpGaD
Irbesartan—JUN—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	6e-05	0.00101	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—malaria	5.91e-05	0.000991	CbGpPWpGaD
Irbesartan—CYP3A4—Biological oxidations—HPGDS—malaria	5.81e-05	0.000975	CbGpPWpGaD
Irbesartan—JUN—MAPK Signaling Pathway—TNF—malaria	5.75e-05	0.000965	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—TLR9—malaria	5.75e-05	0.000964	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SLC4A1—malaria	5.56e-05	0.000933	CbGpPWpGaD
Irbesartan—PTGS1—Selenium Micronutrient Network—IL6—malaria	5.44e-05	0.000912	CbGpPWpGaD
Irbesartan—JUN—Regulation of toll-like receptor signaling pathway—IL6—malaria	5.4e-05	0.000906	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—HLA-B—malaria	5.36e-05	0.000899	CbGpPWpGaD
Irbesartan—JUN—Toll-Like Receptors Cascades—IL6—malaria	5.34e-05	0.000896	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—ACKR1—malaria	5.33e-05	0.000894	CbGpPWpGaD
Irbesartan—JUN—Immune System—FCGR2A—malaria	5.31e-05	0.000891	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—DECR1—malaria	5.28e-05	0.000885	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD36—malaria	5.25e-05	0.000881	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DECR1—malaria	5.23e-05	0.000877	CbGpPWpGaD
Irbesartan—JUN—Integrated Pancreatic Cancer Pathway—TNF—malaria	5.19e-05	0.000871	CbGpPWpGaD
Irbesartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—malaria	5.1e-05	0.000856	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—HPGDS—malaria	5.09e-05	0.000854	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	5.08e-05	0.000853	CbGpPWpGaD
Irbesartan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malaria	5.08e-05	0.000853	CbGpPWpGaD
Irbesartan—JUN—Myometrial Relaxation and Contraction Pathways—IL6—malaria	4.95e-05	0.000831	CbGpPWpGaD
Irbesartan—JUN—SIDS Susceptibility Pathways—IL6—malaria	4.93e-05	0.000826	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CRP—malaria	4.73e-05	0.000794	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HBB—malaria	4.73e-05	0.000794	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—DHFR—malaria	4.72e-05	0.000792	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—SCARB1—malaria	4.67e-05	0.000784	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—TLR4—malaria	4.54e-05	0.000762	CbGpPWpGaD
Irbesartan—JUN—Fc epsilon receptor (FCERI) signaling—IL6—malaria	4.45e-05	0.000747	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—TLR9—malaria	4.29e-05	0.00072	CbGpPWpGaD
Irbesartan—JUN—Cellular Senescence—IL6—malaria	4.28e-05	0.000718	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DHODH—malaria	4.23e-05	0.000709	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—PKLR—malaria	4.22e-05	0.000707	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—malaria	4.16e-05	0.000697	CbGpPWpGaD
Irbesartan—JUN—Circadian rythm related genes—IL6—malaria	4.02e-05	0.000675	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.82e-05	0.00064	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—G6PD—malaria	3.76e-05	0.00063	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism of lipids and lipoproteins—CD36—malaria	3.71e-05	0.000622	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SLC4A1—malaria	3.59e-05	0.000603	CbGpPWpGaD
Irbesartan—EDNRA—GPCR downstream signaling—IL2—malaria	3.52e-05	0.000591	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DHODH—malaria	3.47e-05	0.000582	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DHODH—malaria	3.44e-05	0.000577	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—malaria	3.38e-05	0.000568	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DECR1—malaria	3.38e-05	0.000567	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL18—malaria	3.29e-05	0.000552	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD40LG—malaria	3.28e-05	0.00055	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD8A—malaria	3.24e-05	0.000544	CbGpPWpGaD
Irbesartan—JUN—Cellular responses to stress—IL6—malaria	3.23e-05	0.000542	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL2—malaria	3.2e-05	0.000537	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—CD4—malaria	3.2e-05	0.000537	CbGpPWpGaD
Irbesartan—JUN—Immune System—HLA-B—malaria	3.12e-05	0.000523	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—malaria	3.11e-05	0.000521	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD36—malaria	3.06e-05	0.000513	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HBB—malaria	3.06e-05	0.000513	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SLC4A1—malaria	2.95e-05	0.000495	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DHODH—malaria	2.94e-05	0.000493	CbGpPWpGaD
Irbesartan—UGT1A3—Metabolism—CD36—malaria	2.93e-05	0.000492	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SLC4A1—malaria	2.92e-05	0.000491	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—KDR—malaria	2.92e-05	0.000489	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—malaria	2.89e-05	0.000485	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—HPGDS—malaria	2.87e-05	0.000481	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DECR1—malaria	2.77e-05	0.000465	CbGpPWpGaD
Irbesartan—AGTR1—GPCR downstream signaling—IL2—malaria	2.77e-05	0.000464	CbGpPWpGaD
Irbesartan—JUN—Immune System—CRP—malaria	2.76e-05	0.000463	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DECR1—malaria	2.75e-05	0.000461	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—PKLR—malaria	2.72e-05	0.000457	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—DHFR—malaria	2.66e-05	0.000446	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—malaria	2.65e-05	0.000445	CbGpPWpGaD
Irbesartan—JUN—Immune System—TLR4—malaria	2.64e-05	0.000444	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—SCARB1—malaria	2.63e-05	0.000441	CbGpPWpGaD
Irbesartan—JUN—Immune System—ICAM1—malaria	2.53e-05	0.000425	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL2—malaria	2.51e-05	0.000421	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HBB—malaria	2.51e-05	0.000421	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SLC4A1—malaria	2.5e-05	0.000419	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HBB—malaria	2.49e-05	0.000417	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—G6PD—malaria	2.43e-05	0.000407	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism of lipids and lipoproteins—CD36—malaria	2.39e-05	0.000402	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DECR1—malaria	2.35e-05	0.000394	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—KDR—malaria	2.29e-05	0.000384	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DHODH—malaria	2.27e-05	0.000381	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—PKLR—malaria	2.24e-05	0.000375	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—PKLR—malaria	2.22e-05	0.000372	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HBB—malaria	2.12e-05	0.000356	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—G6PD—malaria	1.99e-05	0.000334	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—G6PD—malaria	1.98e-05	0.000331	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism of lipids and lipoproteins—CD36—malaria	1.95e-05	0.000327	CbGpPWpGaD
Irbesartan—JUN—Immune System—IFNG—malaria	1.93e-05	0.000324	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SLC4A1—malaria	1.93e-05	0.000324	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—PKLR—malaria	1.89e-05	0.000318	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL2—malaria	1.89e-05	0.000317	CbGpPWpGaD
Irbesartan—EDNRA—Signaling by GPCR—IL6—malaria	1.88e-05	0.000316	CbGpPWpGaD
Irbesartan—JUN—Immune System—CD4—malaria	1.86e-05	0.000313	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—HPGDS—malaria	1.85e-05	0.000311	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DECR1—malaria	1.81e-05	0.000304	CbGpPWpGaD
Irbesartan—JUN—Innate Immune System—IL6—malaria	1.73e-05	0.00029	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL1B—malaria	1.72e-05	0.000289	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—DHFR—malaria	1.72e-05	0.000288	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL2—malaria	1.71e-05	0.000288	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—KDR—malaria	1.71e-05	0.000287	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—SCARB1—malaria	1.7e-05	0.000285	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—G6PD—malaria	1.69e-05	0.000283	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism of lipids and lipoproteins—CD36—malaria	1.67e-05	0.000279	CbGpPWpGaD
Irbesartan—PTGS1—Metabolism—CD36—malaria	1.65e-05	0.000277	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HBB—malaria	1.64e-05	0.000275	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—HPGDS—malaria	1.52e-05	0.000255	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—HPGDS—malaria	1.51e-05	0.000253	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL2—malaria	1.48e-05	0.000249	CbGpPWpGaD
Irbesartan—AGTR1—Signaling by GPCR—IL6—malaria	1.48e-05	0.000248	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—PKLR—malaria	1.46e-05	0.000245	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—DHFR—malaria	1.41e-05	0.000237	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—DHFR—malaria	1.4e-05	0.000234	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—SCARB1—malaria	1.4e-05	0.000234	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—SCARB1—malaria	1.38e-05	0.000232	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—G6PD—malaria	1.3e-05	0.000219	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—HPGDS—malaria	1.29e-05	0.000216	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—DHFR—malaria	1.19e-05	0.0002	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—SCARB1—malaria	1.18e-05	0.000198	CbGpPWpGaD
Irbesartan—EDNRA—Signaling Pathways—IL6—malaria	1.11e-05	0.000186	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL2—malaria	1.11e-05	0.000186	CbGpPWpGaD
Irbesartan—CYP2C8—Metabolism—CD36—malaria	1.07e-05	0.000179	CbGpPWpGaD
Irbesartan—JUN—Immune System—IL6—malaria	1.01e-05	0.000169	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—HPGDS—malaria	9.94e-06	0.000167	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—DHFR—malaria	9.22e-06	0.000155	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—SCARB1—malaria	9.12e-06	0.000153	CbGpPWpGaD
Irbesartan—CYP2D6—Metabolism—CD36—malaria	8.76e-06	0.000147	CbGpPWpGaD
Irbesartan—AGTR1—Signaling Pathways—IL6—malaria	8.72e-06	0.000146	CbGpPWpGaD
Irbesartan—CYP2C9—Metabolism—CD36—malaria	8.68e-06	0.000146	CbGpPWpGaD
Irbesartan—CYP1A2—Metabolism—CD36—malaria	7.42e-06	0.000124	CbGpPWpGaD
Irbesartan—JUN—Signaling Pathways—IL6—malaria	6.51e-06	0.000109	CbGpPWpGaD
Irbesartan—CYP3A4—Metabolism—CD36—malaria	5.72e-06	9.6e-05	CbGpPWpGaD
